EP11.03. What Are Favorable Clinicopathological Factors and Types of Therapy for Postoperatively Recurrent NSCLC Patients? - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yuki Matsumura
Meta Tag
Speaker Yuki Matsumura
Topic Metastatic NSCLC: Immunotherapy - Retrospective
clinicopathological factors
types of therapy
post-recurrence survival
non-small cell lung cancer
histological types
EGFR mutations
ALK rearrangements
tyrosine kinase inhibitors
platinum doublet
Powered By